Circulating tumor cells, disease progression, and survival in metastatic breast cancer

The results of the trial indicate that in metastatic breast cancer the level of circulating tumor cells before a new therapy is initiated and, even more important, the level measured at the first follow-up visit are useful predictors of progression-free survival and overall survival. Measurable metastatic breast cancers for levels of circulating tumor cell in 177 patients were tested.